Fig. 6From: Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysisAdverse events, renal toxicity. Subgroup analysis showed a significant increase in the renal toxicity in the drisapersen group, but not in the eteplirsen group, compared with that in the placebo groupsBack to article page